Oriscience Supersensitive ECL Kit (極敏ECL化學(xué)發(fā)光試劑盒)
市場價(jià):¥ 320.00
銷售價(jià):¥ 320.00
貨號(hào):PD203-120ml
貨期:現(xiàn)貨
本產(chǎn)品僅供科研使用。請(qǐng)勿用于醫(yī)藥、臨床診斷或治療,食品及化妝品等用途。
成功加入購物車
Oriscience Supersensitive ECL Kit 是一種基于辣根過氧化物酶(horseradish peroxidase, HRP)的極敏型ECL化學(xué)發(fā)光試劑盒。本試劑盒對(duì)化學(xué)發(fā)光液成分進(jìn)行了優(yōu)化,應(yīng)用了不同于常見的魯米諾-H2O2體系的新型的增強(qiáng)劑和氧化劑,具有靈敏度極高,發(fā)光迅速,亮度強(qiáng),穩(wěn)定性好等特點(diǎn),可使用較高的抗體稀釋倍數(shù)(1:5000~1:10000),因此在很大程度上節(jié)約抗體,且試劑中不含有毒成分,實(shí)驗(yàn)安全性更高。
靈敏度更高
發(fā)光迅速,曝光時(shí)間更短
穩(wěn)定性更好,發(fā)光信號(hào)持久
節(jié)約抗體,背景更低
安全性高
4℃避光保存

Oriscience Supersensitive ECL與某進(jìn)口品牌超敏ECL對(duì)比圖
不同量的Hela細(xì)胞裂解液的Anti-actin Western Blotting結(jié)果(一抗稀釋倍數(shù) 1:10000,二抗稀釋倍數(shù):1:10000)。除使用的ECL底物不同而外,其余實(shí)驗(yàn)條件完全一致。
1. 在配置ECL工作液過程中吸取A液和B液時(shí)應(yīng)避免交叉污染。
2. ECL工作液應(yīng)在每次使用前新鮮配制,避免室溫放置時(shí)間過長。
3. 曝光時(shí)間過長或蛋白過量,將會(huì)導(dǎo)致過曝,使條帶強(qiáng)弱變化失去線性關(guān)系;曝光不足則條帶模糊。
4. ECL發(fā)光液是HRP的顯色底物,因此檢測對(duì)象必須由HRP標(biāo)記。
5. 本產(chǎn)品僅供科研使用。請(qǐng)勿用于醫(yī)藥、臨床診斷或治療,食品及化妝品等用途。
pdf
下載
Q1:背景臟,信噪比低,出現(xiàn)非特異性條帶
a. 抗體特異性低:選用特異性更高的抗體。
b. 顯影時(shí)間過長:在確保獲得足夠強(qiáng)度的目標(biāo)蛋白信號(hào)的前提下,縮短顯影時(shí)間。
c. 抗體孵育和洗膜過程中的污染:確保操作過程中所有試劑和用具的潔凈度。
d. 未進(jìn)行非特異性封閉或封閉不充分:延長封閉時(shí)間,考慮更換合適的封閉劑。
e. 一抗?jié)舛冗^高導(dǎo)致非特異性結(jié)合:稀釋抗體至合適濃度,以更高稀釋度抗體孵育更長時(shí)間(耗時(shí)長但特異性結(jié)合最好)。
f. 二抗與封閉劑非特異性結(jié)合:設(shè)置二抗對(duì)照(不加一抗)以明確,如確實(shí)存在此種情況,可在孵育和洗滌液中加入溫和去污劑,如吐溫20。
OriNote:脫脂奶粉含有酪蛋白,對(duì)于酪蛋白激酶,該蛋白本身就是一種磷酸化蛋白底物,有可能會(huì)結(jié)合磷酸化特異性抗體而易產(chǎn)生高背景。使用 BSA 代替奶粉作為封閉劑。
g. 膜干燥,導(dǎo)致高背景: 在孵育過程中防止膜變干,在任何步驟都保證膜有充分的反應(yīng)液。
h. 未結(jié)合蛋白質(zhì)洗滌不充分:增加洗滌次數(shù)。
Q2:目的條帶過曝
a. 減少蛋白上樣量。
b. 縮短曝光時(shí)間。
c. 用緩沖液適當(dāng)洗滌后重新顯影。
d. 滴加ECL后放置一段時(shí)間再顯影。
Q3:目的條帶弱
a. 轉(zhuǎn)膜不充分:優(yōu)化轉(zhuǎn)膜條件,提高轉(zhuǎn)膜效率。
b. 增加蛋白上樣量。
c. 抗體稀釋倍數(shù)過大:降低抗體稀釋倍數(shù)以提高其濃度。
d. 抗體使用時(shí)間過長導(dǎo)致抗體失效:重新配制抗體。
Q4:背景有不均勻的白色斑點(diǎn)
a. 轉(zhuǎn)膜時(shí)膜上有氣泡或抗體在膜上分布不均:轉(zhuǎn)膜過程中盡量去除氣泡,抗體孵育時(shí)保持搖動(dòng)。
Q5:背景有黑色斑點(diǎn)
a. 抗體結(jié)合了封閉劑:過濾封閉劑。
1. Chen H, Hu Q, Wen T, Luo L, Liu L, Wang L, Shen X. Arteannuin B, a sesquiterpene lactone from Artemisia annua, attenuates inflammatory response by inhibiting the ubiquitin-conjugating enzyme UBE2D3-mediated NF-κB activation. Phytomedicine. 2024 Feb 1;124:155263
2. Tang F, Liu D, Wan F, Zhang L, Xu LY, Zhang JN, Zhao XL, Ao H, Peng C. Ameliorative effect of anisodamine (654-1/654-2) against myocardial dysfunction induced by septic shock via the NF-κB/NLRP-3 or the PI3K-AKT/NF-κB pathway. Phytomedicine. 2024 Jan 1;123:155277
3. Yang Y, Zhang Y, Wang L, et al. Targeting p97/Valosin-Containing Protein Promotes Hepatic Stellate Cell Senescence and Mitigates Liver Fibrosis[J]. DNA and Cell Biology, 2025
4. Shao Y, Liu Y, Huang D, et al. McHDV VP60 Virus-like Particles Elicit Protective Immunity Against Moschus chrysogaster Hemorrhagic Disease in Rabbits[J]. Pathogens, 2024, 13(11): 925
5. Zhang D, Cheng H, Wu J, et al. The energy metabolism-promoting effect of aconite is associated with gut microbiota and bile acid receptor TGR5-UCP1 signaling[J]. Frontiers in Pharmacology, 2024, 15: 1392385
6. Zhan M, Liu X, Xia X, et al. Promotion of neuroinflammation by the glymphatic system: a new insight into ethanol extracts from Alisma orientale in alleviating obesity-associated cognitive impairment[J]. Phytomedicine, 2024, 122: 155147
7. Liu D, Tang F, Zhang L, et al. Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis[J]. Frontiers in Pharmacology, 2024, 15: 1421551
8. Zhang, R., Peng, G., Pan, X., & Tong, N. (2025). Ramulus Mori (Sangzhi) Alkaloids Attenuate Diet-Induced Obesity by Promoting White Adipose Browning and Enhancing Brown Fat Thermogenesis.
9. Zhang, J. N., Li, K. D., Cao, Z. J., Xu, L. Y., Zhao, X. L., Tang, F., ... & Ao, H. (2025). Mechanisms of Magnoliae Officinalis Cortex Volatile Oil in Alleviating 5-Fluorouracil-Induced Mucositis via Multi-Omics Approaches. Drug Design, Development and Therapy, 7503-7525.
10. Yang, Y., Zhang, Y., Wang, L., He, G., Yang, X., & Qing, J. (2025). Targeting p97/valosin-containing protein promotes hepatic stellate cell senescence and mitigates liver fibrosis. DNA and Cell Biology, 44(3), 132-143.
11. Zou, T., Xiao, J., Wei, S., Qing, Y., Song, H., & Hu, Z. (2025). Sophocarpine Alleviates Testicular Ischemia–Reperfusion Injury by Modulating Ferroptosis via the AKT Pathway in Rats. Andrology, e70163.
12. Lei, Y., Li, X., Fan, F., Feng, R., He, J., Zhong, J., ... & Tang, Y. (2025). ERCC1/NGFR affects prognosis in basal-like breast cancer. European Journal of Medical Research, 30(1), 597.
13. Yue, Z., Shi, L., Wang, Z., Hu, R., Peng, Q., Zou, H., ... & Tang, Y. (2025). Glutamine relieves feed restriction-induced ruminal epithelial function damage through histone lysine lactylation in yaks. Journal of Animal Science and Biotechnology, 16(1), 174.
14. Zeng, S., Feng, L., Wu, P., Liu, Y., Ma, Y., Ren, H., ... & Jiang, W. (2025). Glutathione mitigates hypoxia-induced gill damage in juvenile grass carp (Ctenopharyngodon idellus) by alleviating endoplasmic reticulum stress and autophagy. Journal of Animal Science and Biotechnology, 16(1), 1-20.
15. Yan, J., Yu, T., Zhao, X., Liu, Z., Sun, H., Zhang, X., ... & Jing, X. (2025). Engineered resveratrol nanoantioxidants: intestinal targeted oral delivery system of mesalazine for inflammatory bowel disease via spatiotemporal-ecological regulation. Advanced Composites and Hybrid Materials, 8(6), 458.
16. Zhang, P., Wu, Z., Ju, Q., Xu, N., Chen, X., Chen, H., ... & Zhao, Y. (2025). POLE Deficiency Exacerbates Diesel Engine Exhaust‐Induced Genomic Instability and Malignant Transformation of Bronchial Epithelial Cells. Advanced Science, e15943.
17. Chen, J., You, Y., Zhao, W., Zhou, Y., Pu, S., Bai, X., ... & Li, M. (2025). Bortezomib overcomes TRAIL resistance in Burkitt's lymphoma by enhancing apoptosis via reactive oxygen species-mediated DR5 upregulation and MAPK pathway activation. Oncology Letters, 30(6), 588.
18. Fan, F., Feng, R., Zhang, Y., Li, X., & Tang, Y. (2025). Investigation of TMEM41A's function in breast cancer prognosis and its connection to immune cell infiltration. Clinical and Translational Oncology, 27(4), 1569-1585.
19. Wu, F., Guo, Z., Yang, J., Ou, Y., Xie, X., Liao, H., ... & Yang, Z. (2025). A Universal Therapeutic Vaccine Leveraging Autologous Pre‐Existing Immunity to Eliminate in Situ Uniformly Engineered Heterogeneous Tumor Cells. Advanced Materials, 37(9), 2412430.
20. Lei, Y., Li, X., Fan, F., Feng, R., He, J., Zhong, J., ... & Tang, Y. (2025). ERCC1/NGFR affects prognosis in basal-like breast cancer. European Journal of Medical Research, 30(1), 597.
21. Gao, R., Qing, P., Chen, H., Hu, Z., Yang, Q., Lu, C., ... & Qin, L. (2025). Deciphering the Role and Mechanism of Decidual Monocyte‐Derived Macrophage Infiltration in Obstetric Antiphospholipid Syndrome at Single‐Cell Resolution. Advanced Science, 12(41), e03480.
22. Zhang, P., Wu, Z., Ju, Q., Xu, N., Chen, X., Chen, H., ... & Zhao, Y. (2025). POLE Deficiency Exacerbates Diesel Engine Exhaust‐Induced Genomic Instability and Malignant Transformation of Bronchial Epithelial Cells. Advanced Science, e15943.
23. Pu, Y., Dai, X. L., Wang, Y., Chen, Y., Wu, C., Zhou, X., ... & Nie, Y. (2025). Hybrid Lipoplex Boosts Neuron‐Microglia Crosstalk for Treatment of Alzheimer's Disease through Aβ‐Targeted‐Autophagy and ApoE2 Gene Supplementation. Advanced Materials, 2418560.
24. Zhu, Y. J., Dai, X. Y., Zhao, Y. L., Ma, Y. G., Zhao, Z. Z., Su, C. F., ... & Chen, H. (2025). Lyciumines A and B: Two Pyrrole-Fused Alkaloids from the Fruits of Lycium barbarum. Journal of Natural Products, 88(5), 1237-1243.
25. Dai, Y., Yang, Y., Li, H., Wang, Y., Wang, Y., Lin, Y., ... & Zhu, J. (2025). PLIN5 Promotes Lipid Reconstitution in Goat Intramuscular Fat via the PPARγ Signaling Pathway. Biology, 14(11), 1547.
26. Mou, Y., Zhan, X., Liao, W., Niu, Q., Zhang, T., Li, Y., ... & Wang, Z. Evodiamine attenuates hyperuricemia-associated gouty arthritis and renal injury through urate-inflammatory axis modulation. Available at SSRN 5736225.
27. Fan, F., Feng, R., Zhang, Y., Li, X., & Tang, Y. (2025). Investigation of TMEM41A's function in breast cancer prognosis and its connection to immune cell infiltration. Clinical and Translational Oncology, 27(4), 1569-1585.